Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Humnabadkar V"'
Autor:
Fil, Maximilien1 maximilien.fil@univ-amu.fr, Alibert, Sandrine1 sandrine.alibert@univ-amu.fr
Publikováno v:
BioMed. Sep2024, Vol. 4 Issue 3, p220-236. 17p.
Autor:
Rongala, Druva Sarika1 (AUTHOR) druvasarika.barji19@my.stjohns.edu, Patil, Suyash M.1 (AUTHOR), Kunda, Nitesh K.1 (AUTHOR) kundan@stjohns.edu
Publikováno v:
Pharmaceuticals (14248247). Jun2024, Vol. 17 Issue 6, p754. 18p.
Autor:
Hemeda, Loah R.1 (AUTHOR), El Hassab, Mahmoud A.2 (AUTHOR) mahmoud65582@pharm.tanta.edu.eg, Abdelgawad, Mohamed A.3,4 (AUTHOR), Khaleel, Eman F.5 (AUTHOR), Abdel-Aziz, Marwa M.6 (AUTHOR), Binjubair, Faizah A.7 (AUTHOR), Al-Rashood, Sara T.7 (AUTHOR), Eldehna, Wagdy M.8,9 (AUTHOR) wagdy2000@gmail.com, El-Ashrey, Mohamed K.2,10 (AUTHOR)
Publikováno v:
Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2023, Vol. 38 Issue 1, p1-14. 14p.
Autor:
Landge S; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Ramachandran V; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Kumar A; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Neres J; Global Health Institute, École Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland., Murugan K; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Sadler C; iMED Safety Assessment, AstraZeneca, Alderley Park, Macclesfield, SK10 4TF, UK., Fellows MD; iMED Safety Assessment, AstraZeneca, Alderley Park, Macclesfield, SK10 4TF, UK., Humnabadkar V; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Vachaspati P; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Raichurkar A; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Sharma S; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Ravishankar S; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Guptha S; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Sambandamurthy VK; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Balganesh TS; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Ugarkar BG; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Balasubramanian V; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Bandodkar BS; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India., Panda M; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India. manapanda@gmail.com.; Biocon Bristol-Myers Squibb Research Center, Biocon Park, Jigani Link Road, Bangalore, 560099, India. manapanda@gmail.com.
Publikováno v:
ChemMedChem [ChemMedChem] 2016 Feb 04; Vol. 11 (3), pp. 331-9. Date of Electronic Publication: 2016 Jan 11.
Autor:
Landge S; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Mullick AB; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Nagalapur K; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Neres J; École Polytechnique Fédérale de Lausanne, Global Health Institute, Switzerland., Subbulakshmi V; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Murugan K; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Ghosh A; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Sadler C; Global Safety Assessment, AstraZeneca, Alderley Park, Mereside, UK., Fellows MD; Global Safety Assessment, AstraZeneca, Alderley Park, Mereside, UK., Humnabadkar V; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Mahadevaswamy J; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Vachaspati P; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Sharma S; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Kaur P; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Mallya M; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Rudrapatna S; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Awasthy D; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Sambandamurthy VK; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Pojer F; École Polytechnique Fédérale de Lausanne, Global Health Institute, Switzerland., Cole ST; École Polytechnique Fédérale de Lausanne, Global Health Institute, Switzerland., Balganesh TS; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Ugarkar BG; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Balasubramanian V; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Bandodkar BS; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Panda M; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India., Ramachandran V; iMed Infection, AstraZeneca India Pvt Ltd, Bangalore, India. Electronic address: vasanthi_epr@yahoo.com.
Publikováno v:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2015 Dec 15; Vol. 23 (24), pp. 7694-710. Date of Electronic Publication: 2015 Nov 18.
Autor:
Humnabadkar V; AstraZeneca India Pvt. Ltd., Bangalore, India., Madhavapeddi P; AstraZeneca India Pvt. Ltd., Bangalore, India., Basavarajappa H; AstraZeneca India Pvt. Ltd., Bangalore, India Indiana University School of Medicine, Indianapolis, USA., Sheikh MG; AstraZeneca India Pvt. Ltd., Bangalore, India Enzene Bioscience Ltd., Bangalore, India., Rane R; AstraZeneca India Pvt. Ltd., Bangalore, India., Basu R; AstraZeneca India Pvt. Ltd., Bangalore, India., Verma P; AstraZeneca India Pvt. Ltd., Bangalore, India., Sundaram A; AstraZeneca India Pvt. Ltd., Bangalore, India., Mukherjee K; AstraZeneca India Pvt. Ltd., Bangalore, India Alkem Laboratories, Bangalore, India., de Sousa SM; AstraZeneca India Pvt. Ltd., Bangalore, India sunitadesousa@gmail.com.
Publikováno v:
Journal of biomolecular screening [J Biomol Screen] 2015 Feb; Vol. 20 (2), pp. 265-74. Date of Electronic Publication: 2014 Oct 09.
Autor:
Hameed P S; Innovative Medicines, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore 560024, India., Manjrekar P, Chinnapattu M, Humnabadkar V, Shanbhag G, Kedari C, Mudugal NV, Ambady A, de Jonge BL, Sadler C, Paul B, Sriram S, Kaur P, Guptha S, Raichurkar A, Fleming P, Eyermann CJ, McKinney DC, Sambandamurthy VK, Panda M, Ravishankar S
Publikováno v:
ACS chemical biology [ACS Chem Biol] 2014 Oct 17; Vol. 9 (10), pp. 2274-82. Date of Electronic Publication: 2014 Aug 05.
Autor:
Sharma S; AstraZeneca India Pvt. Ltd., Bangalore, India., Gelman E; Global Health Institute, École polytechnique fédérale de Lausanne (EPFL) Station 19, Lausanne, Switzerland., Narayan C; AstraZeneca India Pvt. Ltd., Bangalore, India., Bhattacharjee D; AstraZeneca India Pvt. Ltd., Bangalore, India., Achar V; AstraZeneca India Pvt. Ltd., Bangalore, India., Humnabadkar V; AstraZeneca India Pvt. Ltd., Bangalore, India., Balasubramanian V; AstraZeneca India Pvt. Ltd., Bangalore, India., Ramachandran V; AstraZeneca India Pvt. Ltd., Bangalore, India., Dhar N; Global Health Institute, École polytechnique fédérale de Lausanne (EPFL) Station 19, Lausanne, Switzerland neeraj.dhar@epfl.ch neeladin@gmail.com., Dinesh N; AstraZeneca India Pvt. Ltd., Bangalore, India neeraj.dhar@epfl.ch neeladin@gmail.com.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2014 Oct; Vol. 58 (10), pp. 5801-8. Date of Electronic Publication: 2014 Jul 21.
Autor:
Humnabadkar V; Biosciences, AstraZeneca, Bangalore, India., Prabhakar KR; DMPK and Animal Sciences, AstraZeneca, Bangalore, India., Narayan A; Biosciences, AstraZeneca, Bangalore, India., Sharma S; Biosciences, AstraZeneca, Bangalore, India., Guptha S; Biosciences, AstraZeneca, Bangalore, India., Manjrekar P; Chemistry, AstraZeneca, Bangalore, India., Chinnapattu M; Chemistry, AstraZeneca, Bangalore, India., Ramachandran V; Biosciences, AstraZeneca, Bangalore, India., Hameed SP; Chemistry, AstraZeneca, Bangalore, India., Ravishankar S; Biosciences, AstraZeneca, Bangalore, India., Chatterji M; Biosciences, AstraZeneca, Bangalore, India monalisa.chatterji@astrazeneca.com.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2014 Oct; Vol. 58 (10), pp. 6165-71. Date of Electronic Publication: 2014 Aug 11.
Autor:
Naik M; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Ghorpade S; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Jena LK; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Gorai G; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Narayan A; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Guptha S; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Sharma S; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Dinesh N; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Kaur P; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Nandishaiah R; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Bhat J; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Balakrishnan G; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Humnabadkar V; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Ramachandran V; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Naviri LK; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Khadtare P; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Panda M; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Iyer PS; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India., Chatterji M; Department of Medicinal Chemistry and Department of Biosciences, IMED Infection, AstraZeneca , Bellary Road, Hebbal, Bangalore 560024, India.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2014 Jul 11; Vol. 5 (9), pp. 1005-9. Date of Electronic Publication: 2014 Jul 11 (Print Publication: 2014).